WallStSmart

CryoCell International Inc (CCEL)vsHCA Healthcare, Inc. (HCA)

VS
⚡

Smart Verdict

WallStSmart Research — data-driven comparison

HCA Healthcare, Inc. generates 252742% more annual revenue ($78.70B vs $31.13M). HCA leads profitability with a 8.6% profit margin vs -6.3%. CCEL appears more attractively valued with a PEG of 1.34. HCA earns a higher WallStSmart Score of 57/100 (C).

CCEL

Hold

47

out of 100

Grade: D+

Growth: 6.0Profit: 5.0Value: 7.0Quality: 5.5
Piotroski: 6/9Altman Z: -0.53

HCA

Buy

57

out of 100

Grade: C

Growth: 4.7Profit: 8.0Value: 4.7Quality: 6.0
Piotroski: 5/9Altman Z: 1.71
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

CCELUndervalued (+33.5%)

Margin of Safety

+33.5%

Fair Value

$5.02

Current Price

$4.15

$0.87 discount

UndervaluedFair: $5.02Overvalued
HCASignificantly Overvalued (-67.6%)

Margin of Safety

-67.6%

Fair Value

$317.15

Current Price

$475.57

$158.42 premium

UndervaluedFair: $317.15Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

CCEL3 strengths · Avg: 10.0/10
Return on EquityProfitability
129.2%10/10

Every $100 of equity generates 129 in profit

EPS GrowthGrowth
75.1%10/10

Earnings expanding 75.1% YoY

Debt/EquityHealth
-0.0410/10

Conservative balance sheet, low leverage

HCA5 strengths · Avg: 9.0/10
Return on EquityProfitability
136.3%10/10

Every $100 of equity generates 136 in profit

Debt/EquityHealth
-6.4910/10

Conservative balance sheet, low leverage

Market CapQuality
$104.58B9/10

Large-cap with strong market position

P/E RatioValuation
16.6x8/10

Attractively priced relative to earnings

Free Cash FlowQuality
$3.10B8/10

Generating 3.1B in free cash flow

Areas to Watch

CCEL4 concerns · Avg: 3.0/10
Revenue GrowthGrowth
0.0%4/10

0.0% revenue growth

Market CapQuality
$39.10M3/10

Smaller company, higher risk/reward

Operating MarginProfitability
0.6%3/10

Operating margin of 0.6%

Altman Z-ScoreHealth
-0.532/10

Distress zone — elevated risk

HCA4 concerns · Avg: 4.0/10
PEG RatioValuation
1.554/10

Expensive relative to growth rate

Revenue GrowthGrowth
3.6%4/10

3.6% revenue growth

EPS GrowthGrowth
4.5%4/10

4.5% earnings growth

Altman Z-ScoreHealth
1.714/10

Distress zone — elevated risk

Comparative Analysis Report

WallStSmart Research

Bull Case : CCEL

The strongest argument for CCEL centers on Return on Equity, EPS Growth, Debt/Equity. PEG of 1.34 suggests the stock is reasonably priced for its growth.

Bull Case : HCA

The strongest argument for HCA centers on Return on Equity, Debt/Equity, Market Cap.

Bear Case : CCEL

The primary concerns for CCEL are Revenue Growth, Market Cap, Operating Margin.

Bear Case : HCA

The primary concerns for HCA are PEG Ratio, Revenue Growth, EPS Growth.

Key Dynamics to Monitor

CCEL profiles as a turnaround stock while HCA is a value play — different risk/reward profiles.

HCA carries more volatility with a beta of 1.10 — expect wider price swings.

HCA is growing revenue faster at 3.6% — sustainability is the question.

HCA generates stronger free cash flow (3.1B), providing more financial flexibility.

Bottom Line

HCA scores higher overall (57/100 vs 47/100). CCEL offers better value entry with a 33.5% margin of safety. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

CryoCell International Inc

HEALTHCARE · MEDICAL CARE FACILITIES · USA

Cryo-Cell International, Inc. is dedicated to cell processing and cryogenic cell storage with a focus on collecting and preserving umbilical cord blood stem cells for family use. The company is headquartered in Oldsmar, Florida.

HCA Healthcare, Inc.

HEALTHCARE · MEDICAL CARE FACILITIES · USA

HCA Healthcare is an American for-profit operator of health care facilities that was founded in 1968. It is based in Nashville, Tennessee, and, as of May 2020, owns and operates 186 hospitals and approximately 2,000 sites of care, including surgery centers, freestanding emergency rooms, urgent care centers and physician clinics in 21 states and the United Kingdom.

Visit Website →

Want to dig deeper into these stocks?